Qiagen N.V. (QGEN) Bundle
QIAGEN Shares Increase 2.6 Percent Over 30 Days
QIAGEN N.V. (NYSE:QGEN) shares recorded a 2.6% increase over the 30-day period ending Dec 18, 2025. This growth occurred despite a 3.5% decline in share value over the last 10 trading days.
Financial analysis shows the company holds a Piotroski Score of 8. This metric indicates strength in profitability, liquidity, and operational efficiency. Further details are available in the QGEN-financial-health report and the QGEN-investor-profile.
Market analysts have set a target price of $55 USD for the stock. This valuation implies a potential appreciation of 21.5% from the current trading price. The company operates as a provider of sample and assay technologies for molecular diagnostics and pharmaceutical research, as outlined in the QGEN-history-mission-ownership and QGEN-mission-vision documents.
QIAGEN competes in the molecular diagnostics and research sector against peers including Thermo Fisher Scientific and Illumina. The company focuses on biological sample insights for academic and pharmaceutical applications.
Qiagen N.V. (QGEN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.